Research Papers

25 of 325 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
The Prognostic Value of Serum HBV-RNA during Hepatitis B Virus Infection is Related to Acute-on-Chronic Liver Failure.
Qian K; Xue Y; Sun H; Lu T; Wang Y; Shi X.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints.
Menees SB; Lembo AJ; Chey WD.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Impact of an Abdominal Compression Bandage on the Completion of Colonoscopy for Obese Adults: A Prospective Randomized …
Liu TT; Meng YT; Xiong F; Wei C; Luo S; Zhan SG; Song Y; Li YX; Shi RY; Yao J; Wang LS; Li DF.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
<i>ptk2</i> and <i>mt2a</i> Genes Expression in Gastritis and Gastric Cancer Patients with <i>Helicobacter pylori</i> I…
Ahmadi Hedayati M; Khani D; Sheikhesmaeili F; Nouri B.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Long-Term Survival and Risk Factors in Patients with Hepatitis B-Related Hepatocellular Carcinoma: A Real-World Study.
Zhu Y; Gu LL; Zhang FB; Zheng GQ; Chen T; Jia WD.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The Feasibility and Safety of the Clip-and-Snare Method with a Prelooping Technique for Gastric Submucosal Tumors Remov…
Tang Q; Shi RY; Yao J; Wang LS; Li DF.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Biologic Agents in Crohn's Patients Reduce CD4<sup>+</sup> T Cells Activation and Are Inversely Related to Treg Cells.
Rosseto-Welter EA; D'argenio-Garcia L; Blasco Tavares Pereira Lopes F; Zulim Carvalho AE; Flaquer F; Severo-Lemos V; Viero Nora CC; Steinwurz F; Pires Garcia Oliveria L; Aloia T; Rizzo LV; Pitangueira Mangueira CL; Carvalho KI.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
ERCP-Related Adverse Events in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.
Natt N; Michael F; Michael H; Dubois S; Al Mazrou'i A.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Registered
qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with N…
Gan Q; Huang Y; Zhu C; Zhao S; Fu H; Cai M; Wang J; Zhang C; Guo S; Cao Z; Xie Q.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with…
Yang G; Zhuang L; Sun T; Yeo YH; Tao L; Zhang W; Ma W; Wu L; Yang Z; Yang Y; Xue D; Zhang J; Feng R; Matthias P E; Dooley S; Seki E; Liu P; Liu C.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-…
Chen SH; Lai HC; Su WP; Kao JT; Chuang PH; Hsu WF; Wang HW; Hsieh TL; Chen HY; Peng CY.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Comparison of Endoscopic Radiofrequency Ablation and Argon Plasma Coagulation in Patients with Gastric Low-Grade Intrae…
Wang N; Chai N; Li L; Li H; Zhai Y; Feng X; Liu S; Zhang W; Linghu E.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Usefulness of Noncontrast MRI-Based Radiomics Combined Clinic Biomarkers in Stratification of Liver Fibrosis.
Zhao R; Zhao H; Ge YQ; Zhou FF; Wang LS; Yu HZ; Gong XJ.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Application of Half-Transected and Self-Pulling Esophagojejunostomy in Total Laparoscopic Gastrectomy for Gastric Cance…
Wan H; Xiong J; Chen Y; Wei H; Tang R; Chen C; Sun Q; Xu J; Yi B.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
<i>Clostridioides difficile</i> Infection in Liver Cirrhosis: A Concise Review.
Liu Y; Chen M; Chen M.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent
LncRNA PVT1 Promotes Cell Proliferation, Invasion, and Migration and Inhibits Cell Apoptosis by Phosphorylating YAP.
Ji K; Zhang Q; Song W; Mao T; Guo J; Min C; Zhang C; Tian Z; Li X.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Sulforaphane Ameliorates the Intestinal Injury in Necrotizing Enterocolitis by Regulating the PI3K/Akt/GSK-3<i>β</i> Si…
Bao ZK; Mi YH; Xiong XY; Wang XH.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease.
Jarmakiewicz-Czaja S; Sokal A; Pardak P; Filip R.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent
Does Preoperative Waiting Time Affect the Short-Term Outcomes and Prognosis of Colorectal Cancer Patients? A Retrospect…
Liu XY; Li ZW; Kang B; Cheng YX; Tao W; Zhang B; Zhang H; Wei ZQ; Peng D.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Clinical Evaluation of a Novel Stool Antigen Test Using Bioluminescent Enzyme Immunoassay for Detecting <i>Helicobacter…
Kakiuchi T; Matsuo M; Sakata Y; Fujimoto K.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Sys…
Liu M; Mei K; Tan Z; Huang S; Liu F; Deng C; Ma J; Yu P; Liu X.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis.
Pan Y; Guo R; Lv Y; Cui D; Xie J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Diseas…
Kumar A; Al-Hassi HO; Steed H; Phipps O; Brookes MJ.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Risk Factors of Young-Onset Colorectal Cancer: Analysis of a Large Population-Based Registry.
Danial D; Youssef ED; Maryam BM; Mohammad A; Moein BM; Liliane D.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent
BAR Score Performance in Predicting Survival after Living Donor Liver Transplantation: A Single-Center Retrospective St…
Zakareya T; Taha M; Elzohry H; Darwiesh E; Aglan R; Elhelbawy M; Zakaria H; Deif M; Abbasy M.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent